Table 1. 1H (700.7 MHz), 13C NMR (176.2 MHz), and 31P NMR (283.7 MHz) chemical shift data (δ, ppm) [J, Hz] for S. oralis Uo5Δcps LTA after hydrazine treatment (10).
Residue (assignment) | H-1 C-1 | H-2 C-2 | H-3 C-3 | H-4 C-4 | H-5 C-5 | H-6 C-6 | NAc |
---|---|---|---|---|---|---|---|
Glycerol-(1→ (Gro) | 3.83–3.79* | 3.62–3.58* | 3.70–3.66* | ||||
3.50–3.46* | |||||||
69.5 | 71.3 | 63.1 | |||||
→3)-α-D-Glcp-(1→ (A) | 4.89 [3.6] | 3.63–3.60* | 3.84–3.80* | 3.49–3.46* | 3.71–3.67* | 3.86–3.82* | |
3.77–3.74* | |||||||
99.4 | 71.5 | 83.2 | 68.7 | 72.2 | 61.1 | ||
→3)-β-AATGalp-(1→ (B#) | 4.63 [8.2] | 3.98–3.93* | 3.95–3.91* | 3.37–3.32* | 3.90–3.87* | 1.29 [6.4] | 2.02 |
102.8 | 51.6 | 80.6 | 54.3 | 70.5 | 16.7 | 22.9 | |
175.7 | |||||||
P→6)-β-D-Galp-(1→ (C#) | 4.49/4.48 | 3.56–3.51* | 3.66–3.63* | 3.98–3.96* | 3.83–3.78* | 4.03–3.96* | |
[7.7] | |||||||
105.4/105.2 | 71.2 | 73.1/73.0 | 68.7 | 74.1–73.9* | 64.7–64.5* | ||
→2)-ribitol-(1→ P (Rib-ol) | 4.13–4.08* | 4.15–4.08* | 3.86–3.81* | 3.78–3.73* | 3.84–3.79* | ||
3.94–3.90* | 3.65–3.60* | ||||||
65.6–65.4* | 80.5–80.3* | 72.5 | 72.1 | 63.4 | |||
→4)-β-D-3,6-O-di-P-Cho-GalpNAc (1→ (D) | 4.73 [8.7] | 4.04–3.98* | 4.27–4.23* | 4.24–4.18* | 3.90–3.85* | 4.15–4.11* | 2.07 |
4.09–4.03* | |||||||
102.3 | 52.3–52.1* | 74.6–74.5 | 75.8–75.7 | 73.8–73.6* | 66.3–66.2 | 23.2 | |
175.1 | |||||||
Cho-P-(3-O→ @ D | 4.32–4.28* | 3.73–3.67* | 3.24/3.23 | ||||
4.25–4.20* | |||||||
60.3–60.1* | 66.7–66.5* | 54.6 | |||||
Cho-P-(6-O→ @ D | 4.34–4.28* | 3.71–3.67* | 3.24 | ||||
60.3–60.1* | 66.7–66.5* | 54.6 | |||||
→3)-β-AATGalp-(1→ (B) | 4.69–4.65* | 4.00–3.94* | 4.00–3.95* | 3.50–3.44* | 3.89–3.84* | 1.33–1.29* | 2.06 |
102.5 | 51.3 | 80.6 | 54.5 | 69.4 | 16.8 | 23.0 | |
175.6 | |||||||
(E)→3,P→6)-β-D-Galp-(1→ (C) | 4.55 [7.7] | 3.68–3.63* | 3.78–3.73* | 4.24–4.20* | 3.83–3.78* | 4.03–3.96* | |
105.3 | 69.8 | 77.8 | 65.0 | 74.1–73.9 | 64.7–64.5 | ||
α-D-Galp-(1→ (E) | 5.16 [3.6] | 3.88–3.84* | 3.97–3.93* | 4.03–4.00* | 4.22–4.18* | 3.74–3.71* | |
96.1 | 68.9 | 70.0 | 69.8 | 71.4 | 61.6 | ||
(C#)→3)-β-AATGalp-(1→ (B#,term) | 4.65 [8.2] | 3.99–3.95* | 3.99–3.95* | 3.37–3.32* | 3.89–3.84* | 1.33–1.29* | 2.07 |
102.6 | 51.4 | 80.6 | 54.7 | 70.5 | 16.8 | 22.9 | |
175.7 | |||||||
β-D-3,6-O-di-P-Cho-GalpNAc-(1→ (Dterm) | 4.76 [8.6] | 4.10–4.06* | 4.24–4.20* | 4.19–4.17* | 3.90–3.86* | 4.08–4.04* | 2.09 |
102.0 | 52.2–52.0* | 75.9–75.8 | 67.2 | 70.6–70.5* | 64.8 [4.8] | ||
23.3 | |||||||
175.5 | |||||||
Cho-P-(3-O→@ Dterm | 4.31–4.26* | 3.69–3.65* | 3.22 | ||||
4.24–4.20* | |||||||
60.3–60.1* | 66.7–66.5* | 54.6 | |||||
Cho-P-(6-O→@ Dterm | 4.35–4.31* | 3.71–3.67* | 3.24 | ||||
60.3–60.1* | 66.7–66.5* | 54.6 | |||||
31P | P-1Rib-ol/6C(#) 1.21; P-1Rib-ol/6C 1.15, 1.13; P-6D(term)/CH2OCho 0.29; P-6D/CH2OCho 0.18; P-3D(term)/CH2OCho −0.80; P-3D/CH2OCho −1.04, −1.07. |
*non-resolved multiplet.